World Equity Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.36M Buy
1,971
+87
+5% +$88.9K 0.53% 41
2026
Q1
$1.73M Sell
1,884
-31
-2% -$31.4K 0.45% 43
2025
Q4
$2.06M Sell
1,915
-58
-3% -$55.5K 0.57% 35
2025
Q3
$1.51M Buy
1,973
+856
+77% +$637K 0.34% 63
2025
Q2
$871K Buy
1,117
+4
+0.4% +$3.11K 0.24% 90
2025
Q1
$919K Buy
1,113
+306
+38% +$255K 0.26% 85
2024
Q4
$623K Buy
807
+51
+7% +$42.2K 0.13% 161
2024
Q3
$670K Sell
756
-36
-5% -$32.4K 0.24% 99
2024
Q2
$717K Sell
792
-1,014
-56% -$811K 0.21% 122
2024
Q1
$1.4M Sell
1,806
-38
-2% -$27K 0.29% 90
2023
Q4
$1.07M Sell
1,844
-1,122
-38% -$655K 0.22% 105
2023
Q3
$1.59M Buy
2,966
+1,492
+101% +$769K 0.33% 71
2023
Q2
$691K Buy
+1,474
New +$618K 0.2% 126
2023
Q1
Sell
-1,716
Closed -$628K 553
2022
Q4
$628K Buy
1,716
+18
+1% +$6.38K 0.15% 155
2022
Q3
$549K Buy
1,698
+5
+0.3% +$1.58K 0.14% 154
2022
Q2
$549K Sell
1,693
-232
-12% -$69.6K 0.14% 169
2022
Q1
$551K Buy
+1,925
New +$495K 0.12% 193

Other funds holding LLY

World Equity Group's LLY Position: Q2 2026 in Review

World Equity Group increased its Eli Lilly (LLY) stake by 4.6% in Q2 2026, buying an estimated $88.9K and bringing the position to 1,971 shares worth $2.36M. The position accounts for 0.53% of the portfolio, ranked #41.

World Equity Group first reported a position in LLY in Q1 2022 and has held it in 17 quarters since. 1,102 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • World Equity Group held 1,971 shares of Eli Lilly worth $2.36M as of Q2 2026.
  • World Equity Group bought 87 Eli Lilly shares in Q2 2026, an estimated $88.9K.
  • Eli Lilly made up 0.53% of World Equity Group's portfolio in Q2 2026, its #41 holding.
  • World Equity Group first reported a position in Eli Lilly in Q1 2022 and has held it in 17 quarters since.
  • 1,102 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on World Equity Group's 13F filing for Q2 2026, filed 9 Jul 2026.